Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Enforcing Post-Marketing Requirements
A recent Food and Drug Administration (FDA) Warning Letter suggests that the agency will not hesitate, when necessary, to exercise its power to enforce post-marketing requirements (PMRs) for approved drug products. (The Warning Letter is available at www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm293490.htm. While the Warning Letter is available publicly, we will not disclose here the company that received the correspondence.) The Warning Letter states that the recipient company failed to submit a required study protocol and final study report, pursuant to the company's PMRs and, therefore, the drug products are misbranded under the Federal Food, Drug, and Cosmetic Act (FDCA) (21 U.S.C. ' 352(z)). The Warning Letter is significant, because it demonstrates that the agency will take enforcement action against a company for failure to comply with PMRs, creating yet another area of enforcement that can lead to cascading effects, such as increased product liability exposure, for the recipient company.
Drawing FDA reproach for failure to comply with the FDCA is bad enough, but, due to their public availability, FDA enforcement letters also increase a company's potential liability exposure. The FDA posts such enforcement letters on its website, which means that anyone, including would-be plaintiffs and their attorneys, may use the findings in the letter to bolster potential product liability claims against the recipient company. In light of the FDA's apparent readiness to issue such letters, companies should take extra care to comply with PMRs and other FDA requirements, both to enhance regulatory compliance and to reduce liability risk.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Judge Rules Shaquille O'Neal Will Face Securities Lawsuit for Promotion, Sale of NFTs
A federal district court in Miami, FL, has ruled that former National Basketball Association star Shaquille O'Neal will have to face a lawsuit over his promotion of unregistered securities in the form of cryptocurrency tokens and that he was a "seller" of these unregistered securities.
Why So Many Great Lawyers Stink at Business Development and What Law Firms Are Doing About It
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Blockchain Domains: New Developments for Brand Owners
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.
'Insurable Interest' and the Scope of First-Party Coverage
This article reviews the fundamental underpinnings of the concept of insurable interest, and certain recent cases that have grappled with the scope of insurable interest and have articulated a more meaningful application of the concept to claims under first-party property policies.